Panel Partly Reverses, Says Diabetes Treatment Is Patent-Eligible
WASHINGTON, D.C. — Although reversing and remanding a New Jersey federal judge’s determination that various claims of one patent covering a type of treating type 2 diabetes mellitus is drawn to...To view the full article, register now.
Already a subscriber? Click here to view full article